B4GALT1 and pancreatic ductal adenocarcinoma: PANC-1 cells, a widely used model for pancreatic ductal adenocarcinoma (PDAC) that exhibits high expression of B4GALT1, were chosen to evaluate the anticancer potential of compound 1105486.